KATELYNN MANN: Open Payments
NPI 1609379890 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,031 in 322 payments from 21 companies in 2025. Trend: 2023 $2,384 · 2024 $4,550 · 2025 $8,031
Food & beverage: $5,724Honoraria: $2,000Travel & lodging: $223Education: $84
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 25 | $2,902 |
| ABBVIE INC. | 69 | $1,233 |
| Janssen Biotech, Inc. | 31 | $751 |
| Takeda Pharmaceuticals U.S.A., Inc. | 41 | $668 |
| PFIZER INC. | 32 | $445 |
| Celltrion USA Inc. | 18 | $318 |
| Ardelyx, Inc. | 20 | $297 |
| Madrigal Pharmaceuticals | 12 | $184 |
| Phathom Pharmaceuticals, Inc. | 12 | $180 |
| Regeneron Healthcare Solutions, Inc. | 6 | $177 |
Products named: Sucraid, TREMFYA, RINVOQ, ENTYVIO, SKYRIZI, VEGZELMA, IBSRELA, DUPIXENT.
Industry payments across TX — which companies pay providers there.
